CClinicalTrials.gg
CompletedNCT01531010Updated Feb 10, 2012

Pressure-limited Ventilation Versus Volume-targeted Ventilation in Preterm Newborns

An interventional study of Ventilation protocol delivered by the SLE5000 ventilator in Neonatal Respiratory Failure, sponsored by King's College London. Completed at 1 site in United Kingdom. Open to participants aged Up to 24 Hours. Per ClinicalTrials.gov, last updated 2012-02-10.

Sponsored by King's College London · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
Up to 24 Hours
Sex
All
01

Study summary

Aims: There is increasing evidence that volume-targeted ventilation (VTV) holds benefits for preterm infants in comparison to pressure-limited ventilation. This study aims to compare pressure-limited to VTV in preterm infants.

Hypothesis: Volume-targeted will be associated with more rapid achievement of weaning criteria compared to pressure-limited ventilation

Primary outcome: Time taken to achieve pre-specified weaning criteria.

Methods: Ventilated infants less than 34 weeks gestational age at birth were recruited within the first 24 hours of life and randomly allocated to receive either pressure-limited or VTV. Adjustments to ventilator settings were made according to the trial protocol. Infants were deemed to have met failure criteria if they required HFOV, required peak pressures of more than 26 cm of water or developed pulmonary haemorrhage. Analysis will be by intention-to-treat.

02

Conditions studied

  • Neonatal Respiratory Failure

Keywords

  • Neonate
  • Premature
  • Pressure limited ventilation
  • Volume ventilation
03

In context

Respiratory Insufficiency

1,650 studies on the registry are indexed under Respiratory Insufficiency; 296 are open to participants now.

This study's enrollment of 40 is below the median of 55 across 1,043 interventional studies indexed under Respiratory Insufficiency.

Browse Respiratory Insufficiency studies →

Lead sponsor

King's College London is the lead sponsor of 506 studies on the registry; 125 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Up to 24 Hours
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Mechanically ventilated
  • \<34 weeks gestation
  • Within first 24 hours of life

Exclusion criteria

Exclusion Criteria:

  • Congenital diaphragmatic hernia
  • Congenital heart disease
  • Oesophageal atresia
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
40 participants (actual)

Study arms

  • Active comparator
    Pressure-limited ventilation

    Device: Ventilation protocol delivered by the SLE5000 ventilator

  • Active comparator
    Volume-targeted ventilation

    Device: Ventilation protocol delivered by the SLE5000 ventilator

Interventions

  • DeviceVentilation protocol delivered by the SLE5000 ventilator

    In pressure-limited ventilation arm, preferentially wean pressure till weaning criteria achieved, then wean rate. In volume-targeted ventilation arm, set target volume at 5ml/kg and wean rate. In both arms, aim to keep blood gases within normal limits.

06

What researchers measure

Primary outcomes

  1. Time to achieve weaning criteria

    Peak inspiratory pressure (PIP) of 16 cm of water or less AND fraction of inspired oxygen of 0.4 or less for at least 6 hours

07

Study locations

1 site
  • King's College Hospital NHS Foundation Trust
    London, SE5 9RS, United Kingdom
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 10, 2012, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01531010
Lead sponsor
King's College London
Responsible party
Anne Greenough (Professor of Neonatology and Clinical Respiratory Physiology, King's College London) — Principal investigator
First posted
Feb 10, 2012
Start date
Jul 2010
Primary completion
Feb 2012
Completion
Feb 2012
Last update
Feb 10, 2012

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2012. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion